Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assembly of a biomimetic copper-based nanocomplex for alleviating hypoxia to enhance cuproptosis against osteosarcoma and lung metastasis. | Acta Biomater | 2025 | 39710219 | PubTator, text mining | PubMed |
| Novel insights into cuproptosis in alcoholic liver disease using bioinformatics analysis and experimental validation. | Int Immunopharmacol | 2025 | 39709914 | PubTator, text mining | PubMed |
| Cuproptosis and Serine Metabolism Blockade Triggered by Copper-Based Prussian Blue Nanomedicine for Enhanced Tumor Therapy. | Small | 2025 | 39676407 | PubTator, text mining | PubMed |
| Tumor microenvironment-regulated nanoplatform for enhanced chemotherapy, cuproptosis and nonferrous ferroptosis combined cancer therapy. | J Mater Chem B | 2025 | 39652201 | PubTator, text mining | PubMed |
A metal-organic framework functionalized CaO2-based cascade nanoreactor induces synergistic cuproptosis/ferroptosis and Ca2+ overload-mediated mitochondrial damage for enhanced sono-chemodynamic immunotherapy. | Acta Biomater | 2025 | 39637958 | PubTator, text mining | PubMed |
| Autoantibodies Against Dihydrolipoamide S-Acetyltransferase Are Not Associated With Immune-Mediated Neuropathies. | Neurol Neuroimmunol Neuroinflamm | 2025 | 39556782 | PubTator, text mining | PubMed |
| Diagnostic uncertainties in patients with bacteraemia: impact on antibiotic prescriptions and outcome. | J Antimicrob Chemother | 2025 | 39508377 | PubTator, text mining | PubMed |
| Copper-coordinated nanomedicine for the concurrent treatment of lung cancer through the induction of cuproptosis and apoptosis. | Eur J Pharm Sci | 2025 | 39437977 | PubTator, text mining | PubMed |
| Screening and validating genes associated with cuproptosis in systemic lupus erythematosus by expression profiling combined with machine learning. | Biomol Biomed | 2025 | 39388708 | PubTator, text mining | PubMed |
| PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation-mediated gene expression. | Protein Cell | 2025 | 39311688 | PubTator, text mining | PubMed |
| Redox homeostasis disruptors enhanced cuproptosis effect for synergistic photothermal/chemodynamic therapy. | J Colloid Interface Sci | 2025 | 39236435 | PubTator, text mining | PubMed |
| Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials. | Neural Regen Res | 2025 | 39104166 | PubTator, text mining | PubMed |
| Understanding the Dynamics of consumer behaviour and purchase intentions for Green Cosmetic Products in North India: A Gender-Neutral Approach. | F1000Res | 2024 | 39916984 | PubTator, text mining | PubMed |
| Exploring prognosis and therapeutic strategies for HBV-HCC patients based on disulfidptosis-related genes. | Front Genet | 2024 | 39882072 | PubTator, text mining | PubMed |
| Antibodies directed against bacterial antigens in sera of Polish patients with primary biliary cholangitis. | Front Cell Infect Microbiol | 2024 | 39844835 | PubTator, text mining | PubMed |
| Intention to khat chewing among youths in Raya-Azebo district, southern zone of Tigray, Ethiopia: application of the theory of planned behavior. | Front Public Health | 2024 | 39839406 | PubTator, text mining | PubMed |
| A clinical study showing the expression characteristics of cuproptosis markers in cases with Wilson disease. | Medicine (Baltimore) | 2024 | 39809184 | PubTator, text mining | PubMed |
| The study on cuproptosis in Alzheimer's disease based on the cuproptosis key gene FDX1. | Front Aging Neurosci | 2024 | 39759399 | PubTator, text mining | PubMed |
| Exploring the acceptance of virtual reality training systems among construction workers: a combined structural equation modeling and artificial neural network approach. | Front Public Health | 2024 | 39744356 | PubTator, text mining | PubMed |
| Serum DLAT Is a Potential Diagnostic Marker in AFP-Negative HCC. | Biol Pharm Bull | 2024 | 39710381 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=16